Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMothercare Regulatory News (MTC)

Share Price Information for Mothercare (MTC)

Share Price is delayed by 15 minutes
Get Live Data
0.75    -0.25 (-25.00%)
Bid:
0.705
Ask:
0.895
Spread: 0.19 (26.95%)
Market Cap: £4.23m
MTC Live PriceLast checked at - London Stock Exchange

Intraday Mothercare Share Chart

Pre-close trading update

13 Apr 2026 07:00

Pre-close trading update
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

Mothercare plc

Pre-close trading update

Mothercare plc ("Mothercare" or "the Company"), the leading specialist global brand for parents and young children, today issues a pre-close trading update for the 52 week period to 28 March 2026 (“FY26”). Comparatives are based on the 52 week period to 29 March 2025. This update is based upon draft figures pending finalisation of the year end audit.

• Unaudited worldwide retail sales by franchise partners of £180 million for the year, representing a decline of 22% on last year (19% down at constant currency)

• Adjusted EBITDA for FY26 at approximately £1.25 million

• Net borrowings of £5.7 million at the year end (March 2025: £3.7 million).

• Pension scheme deficit remains at £35 million as at 31 December 2025, which is the latest available estimate (March 2025: £35 million) on a technical provisions basis.

The performance reflects variously the end of our exclusive distribution relationship with Boots at the end of 2025, foreign exchange rate impacts and the longstanding uncertainty in our Middle Eastern markets, including the more recent impact of the Iran war in the last month of the period.

EBITDA before adjusting items for FY26, is now expected to be approximately £1.25 million, compared to the £3.5 million adjusted EBITDA for the period to March 2025. We estimate that the impact of the war in the Middle East, in the last month of the period under review, to be approximately £0.1m.

The underlying strength of the business is demonstrated by the fact that excluding the Middle East and the UK, where we continue to believe that there remains a greater opportunity for the brand and a new partner in the UK, on a like for like basis our total retail sales were positive for the full year to March 2026.

There has been no material change to the Group’s financial position since the announcement made on 20 February 2026, setting out the successful and timely refinancing of the Group’s debt facilities and the deferral of contributions to the Group’s pension schemes.

Clive Whiley, Chairman of Mothercare, commented:

“Our results for last year reflect the impact of the continuing uncertainty on our franchise partners’ operations in the Middle East, where any longer-term impact upon supply chains remains unclear at this stage, and the underlying profitability and cash generation of our asset-light franchise system.

The full refinancing of our debt facilities in February 2026 has bought additional time to engineer a more comprehensive solution to harvest the value of the brand IP and the significant operational gearing available to an expanded business. In these circumstances the recent financial performance has been usefully resilient as we look to FY27, whilst acknowledging the impact of the continuing disruption from events in the Middle East.

Given the external factors influencing some of the Company’s key operating markets, our immediate priority remains to support our franchise partners, ultimately for the benefit of our own underlying business, where the strength of the Mothercare brand endures. We remain in discussions with several parties to restore critical mass, a process greatly assisted by the recent alignment of the first-charge debt instrument with our equity.

I would like to thank all of our colleagues and stakeholders for their support and efforts in difficult circumstances, and the board remains determined to optimise the brand IP for the benefit of all stakeholders.“

Investor and analyst enquiries to:

Mothercare plc  Email: investorrelations@mothercare.comClive Whiley, ChairmanAndrew Cook, Chief Financial Officer Deutsche Numis Tel: 020 7260 1000(NOMAD & Joint Corporate Broker)  Luke BordewichAneesh Oza

Cavendish Capital Markets Limited  Tel: 020 7220 0500(Joint Corporate Broker) 

Matt Goode

This announcement contains information that is inside information for the purposes of Article 7 of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended (the Market Abuse Regulation ("MAR")). Upon the publication of this announcement, such information will no longer constitute inside information. Andrew Cook, the Company's CFO, is the person responsible for making the notification for the purposes of Article 17 of MAR.

Date   Source Headline
6th Apr 20067:00 amRNSTrading Statement
5th Apr 20069:29 amRNSHolding(s) in Company
31st Mar 20069:47 amRNSHolding(s) in Company
22nd Mar 20061:50 pmRNSHolding(s) in Company
9th Mar 200611:50 amRNSHolding(s) in Company
9th Mar 20067:57 amRNSHolding(s) in Company
6th Mar 20068:36 amRNSDirector/PDMR Shareholding
23rd Feb 20062:23 pmRNSHolding(s) in Company
16th Feb 200612:28 pmRNSDirector/PDMR Shareholding
6th Feb 20063:39 pmRNSDirector/PDMR Shareholding
30th Jan 200610:00 amRNSNew Finance Director
25th Jan 20061:04 pmRNSDirector/PDMR Shareholding
24th Jan 200612:01 pmRNSDirector/PDMR Shareholding
11th Jan 20067:00 amRNSTrading Statement
29th Dec 20059:45 amRNSDirectorate Change
22nd Dec 20053:23 pmRNSDirector/PDMR Shareholding
8th Dec 20059:15 amRNSAppoints New Finance Director
2nd Dec 20052:12 pmRNSSAR 3 - Mothercare Plc
29th Nov 20052:18 pmRNSDoc re. Interim Report
28th Nov 20051:31 pmRNSDirector/PDMR Shareholding
23rd Nov 20059:46 amRNSDirector/PDMR Shareholding
21st Nov 20053:21 pmRNSDirector/PDMR Shareholding
21st Nov 20051:11 pmRNSDirector/PDMR Shareholding
21st Nov 20059:19 amRNSDirector/PDMR Shareholding
17th Nov 20057:00 amRNSInterim Results
13th Oct 20057:00 amRNSTrading Statement
5th Oct 20058:32 amRNSDirector/PDMR Shareholding
28th Sep 20057:00 amRNSNotice of Results
17th Aug 20051:14 pmRNSDirector/PDMR Shareholding
5th Aug 20059:29 amRNSDirector/PDMR Shareholding
27th Jul 20052:30 pmRNSHolding(s) in Company
22nd Jul 200511:07 amRNSDirector/PDMR Shareholding
19th Jul 20052:35 pmRNSDirector/PDMR Shareholding
19th Jul 20058:45 amRNSHolding(s) in Company
15th Jul 20057:00 amRNSAdoption of IFRS
15th Jul 20057:00 amRNSAGM Statement
7th Jul 20054:21 pmRNSDirector/PDMR Shareholding
1st Jul 20059:03 amRNSBlocklisting Interim Review
10th Jun 200510:13 amRNSDirector Shareholding
9th Jun 200510:34 amRNSAnnual Report and Accounts
9th Jun 20059:40 amRNSDirector Shareholding
24th May 20059:03 amRNSHolding(s) in Company
19th May 20057:01 amRNSFinal Results
12th May 20059:01 amRNSHolding(s) in Company
6th May 20059:35 amRNSHolding(s) in Company
21st Apr 200511:51 amRNSHolding(s) in Company
6th Apr 20053:19 pmRNSHolding(s) in Company
31st Mar 20057:01 amRNSTrading Statement
1st Mar 20055:00 pmRNSHolding(s) in Company
11th Feb 200511:17 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.